Intel meltdown rages on: Opening Bid top takeaway
They got a small catalyst this morning in an earnings miss from Home Depot (HD), although the home improvement retailer did reiterate its sales and profit outlook.
Attention will now turn to earnings results out of Target (TGT) and Walmart (WMT) this week, then a closely watched speech by Fed Chair Jerome Powell on Friday at Jackson Hole.
It may not feel this way, but the markets haven't done much in the past week. The Dow Jones Industrial Average (^DJI), Nasdaq Composite (^IXIC), and S&P 500 (^GSPC) are flat over this stretch.
Bring on that Powell speech.
Stock analysis: Intel
With chatter that the government is nearing taking a 10% stake in Intel, I guess one shouldn't be shocked the bruised tech giant is hoping to gain some Street cred on its future product roadmap by tapping SoftBank and Masayoshi Son for $2 billion. Embattled Intel CEO Lip-Bu Tan also gains a Trump friend in Masa.
Son said in a statement he sees Intel playing a "critical" role in US chip development.
It's still something to see this unfolding at Intel, which has billions in cash and is not in a financial death spiral. Given Masa's close ties to the Trump administration, I suspect the government stake announcement could be next.
A spokesperson for the Trump administration didn't return Yahoo Finance's requests for comment.
Per Yahoo Finance data, SoftBank's $2 billion investment will give it about a 2% stake in Intel, enough to be its fifth-largest shareholder.
"We're not there yet," Moor Insights & Strategy analyst Patrick Moorhead said on Opening Bid on whether Intel is near a financial crisis. "But the big 'if' is how much more market share can AMD take from Intel?"
Deeper dive: Home Depot
Speaking of uncertainty, Home Depot is out with an earnings miss. The company's CFO downplayed the miss in a call I had with him this morning, pointing to sales strength late in the quarter and a reiterated outlook. Brutal results from Whirlpool (WHR) a few weeks ago also should have teed up this report for investors.
But the red flags in the report were as clear as a nail sticking up through a piece of plywood.
"Against the shortfall, we believe the shares could be under modest pressure with commentary on this morning's call key for gaining confidence in the acceleration," Stifel analyst Andrew Carter said.
Yahoo Finance checklist: Home Depot earnings day wins and losses
Wins: US sales finished the quarter strong; outlook reiterated; margins held up despite tariffs
Losses: An earnings miss is an earnings miss; interest rate cut needed to reawaken big remodeling projects
Home Depot CFO Richard McPhail to Yahoo Finance
On passing tariffs on to consumers:
'For some imported goods, tariff rates are higher today than they were when we reported our first quarter. So while we won't see broad-based price movement across our assortment, there will be some modest price movement in some categories."
On the impact of potential interest rate cuts:
'Our customers are looking at long rates right now; we think that the most important borrowing rates for our customers are mortgage rates and HELOC rates. They are still quite elevated relative to recent history, and we know that is leading our customers to defer large projects. It's hard to say what rates may have to do to unlock that spend on large projects, but our customers do tell us they're deferring, they're not canceling."
Brian Sozzi is Yahoo Finance's Executive Editor and a member of Yahoo Finance's editorial leadership team. Follow Sozzi on X @BrianSozzi, Instagram, and LinkedIn. Tips on stories? Email brian.sozzi@yahoofinance.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Bankrupt jewelry retailer Claire's to sell its North America business
(Reuters) -Fashion jewelry retailer Claire's said on Wednesday it would sell its North America business to private equity firm Ames Watson for an undisclosed amount, as the company aims to cut losses while navigating ongoing U.S. bankruptcy proceedings. The retailer operating more than 2,300 stores across 17 countries in North America and Europe, disclosed $690 million in debt in U.S. bankruptcy court filings in Delaware earlier this month, marking its second bankruptcy protection filing since 2018. "The sale of these stores and Claire's IP to Ames Watson will significantly benefit the Company's efforts to create value through its Restructuring Proceedings," the company, which sells necklaces, bracelets and accessories, including headphones and soft toys, said. The sale requires approval from the U.S. and Canadian courts. Ames Watson is a permanent capital holding company generating more than $2 billion in revenue, according to its website. It acquires, transforms, and partners with middle-market companies to build long-term value. Claire's has suffered in recent years from increased competition, high rent costs, and new tariffs on imports from supplier nations such as China, Thailand and Vietnam. The company said liquidation will continue for its other North American stores that are not being sold. "We are glad to reach this definitive agreement to sell a portion of our North America operations to Ames Watson and maximize the value of our company for all our stakeholders," CEO Chris Cramer said. Ames Watson co-founder Lawrence Berger said that the firm was "committed to investing in its (Claire's) future by preserving a significant retail footprint across North America."
Washington Post
3 minutes ago
- Washington Post
White House creates account on TikTok, the app Trump once tried to ban
The White House launched an account on the popular video app TikTok on Tuesday, sharing a number of videos, including one in which President Donald Trump declares: 'I am your voice.' The U.S. has had a rocky relationship with the Chinese-owned video app across multiple administrations. Federal employees are banned from downloading it on work devices — with limited exceptions — because of concerns that China could collect Americans' user data.
Forbes
3 minutes ago
- Forbes
Epic's Bold Move: Healthcare's Star Trek Moment With Intelligent AI Agents
Epic, long a dominant force in electronic medical records (EMR), has just taken a leap into the future of healthcare AI. This week, CEO Judy Faulkner announced that Epic is moving beyond traditional artificial intelligence, coining the term 'healthcare intelligence' to describe its new approach: developing intelligent AI agents within its EMR to transform the entire healthcare ecosystem. The move is a bold, strategic play—one that brings the visionary technologies of Star Trek into real-world patient care. At the core of this AI transformation is Epic's Cosmos dataset, encompassing over 300 million patient records and more than 16 billion encounters across four countries—a formidable advantage that sets Epic apart from its competitors. Epic's new AI agents are at the heart of this transformation: • Emmie, the patient-facing advocate, acts as a personal navigator for care—scheduling, reminders, education, and MyChart-based clinical guidance. She functions like Star Trek's Universal Translator, breaking down language and literacy barriers while delivering personalized guidance. • ART, the clinician copilot, extends AI scribing, pre-visit summaries, order suggestions, and real-time evidence-based guidance. ART embodies the Ship's Computer, allowing clinicians to ask complex questions naturally and receive actionable, context-aware answers in real time. • Cosmos AI, powered by Epic's enormous dataset, supports diagnosis, treatment planning, and predictive analytics at scale. It is the Medical Tricorder, instantly synthesizing labs, imaging, notes, and genomics to propose care pathways and support clinical decision-making. • Penny, the administrative optimizer, tackles prior authorization, revenue capture, and operational bottlenecks. She mirrors the Holodeck EMH, acting as an autonomous support system that extends both clinical and operational capacity, especially in high-demand or underserved settings. Beyond these agents, Epic is embedding Predictive Health Monitoring, mirroring the Star Trek sensors that detect physiological changes before symptoms appear. AI-driven models now identify risk for deterioration, sepsis, readmissions, and other complications, enabling proactive intervention. Epic's strategy raises key questions for the broader healthcare ecosystem: • How will these AI agents integrate with smaller health systems, which historically relied on lighter EHR solutions or Community Connect models? Can pooled resources and nimble implementations allow these systems to adopt Epic without prohibitive costs? • What role will payers play as AI-driven predictive models inform coverage decisions, pre-authorization, and risk stratification? Could these tools reshape payer-provider negotiations or accelerate value-based care adoption? Could this ultimately address payers' long-standing transparency challenges with claims data? • How will pharmacies leverage ART and Cosmos AI for medication management, adherence monitoring, and personalized therapy recommendations? • Can clinical trial enrollment be streamlined through AI-guided matching, making research more accessible and inclusive for patients across diverse settings? • Governance: How will health systems ensure safe, ethical, and compliant use of AI agents across clinical and operational workflows? Who sets the standards, monitors performance, and maintains accountability when agentic AI decisions influence patient care or challenge provider decisions? Strategically, Epic is partnering deeply with Microsoft, leveraging Azure AI to power its AI scribing capabilities. This ensures scale, reliability, and long-term alignment while preventing fragmentation from third-party solutions. ART, Emmie, Cosmos AI, and Penny together create a unified, interoperable ecosystem—one that consolidates Epic's market power, enhances operational efficiency, and raises the bar for competitors. For patients, the benefits are immediate: a single sign-on for MyChart across all sites, AI-powered wound assessments, integrated clinical trial enrollment, and personalized guidance across the entire care journey. For clinicians, the EMR becomes a co-pilot rather than a cumbersome tool, guiding decision-making, reducing administrative burden, and supporting evidence-based care. Final Perspective Epic's AI strategy represents a healthcare Star Trek moment: intelligent, agentic systems that empower human operators, anticipate problems before they occur, and extend care capabilities across every layer of the ecosystem. It is not just about technology—it's a bold vision for a fully connected, intelligent healthcare universe where hospitals, payers, pharmacies, and patients interact seamlessly, and the future of care becomes more predictive, efficient, and patient-centric.
